🇺🇸 IV dexamethasone in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 2
Most-reported reactions
- Acute Respiratory Failure — 1 report (50%)
- Diabetes Mellitus — 1 report (50%)
Frequently asked questions
Is IV dexamethasone approved in United States?
IV dexamethasone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for IV dexamethasone in United States?
University Health Network, Toronto is the originator. The local marketing authorisation holder may differ — check the official source linked above.